Abstract

EPH151 Clinical and Economic Benefits of Prompt Initiation of Single-Inhaler Triple Therapy in COPD Patients in England Following an Exacerbation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Combination adjunctive nebulized furosemide and salbutamol versus single agent therapy in COPD patients: A randomized controlled trial
Mohammadali Saba ... Babak Haghpanah
Annals of Medicine and Surgery | VOL. 57
Mohammadali Saba, et. al.Mohammadali Saba ... Babak Haghpanah
18 Jul 2020
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data
Afisi Ismaila ... Wilhelmine Meeraus
-
Afisi Ismaila, et. al.Afisi Ismaila ... Wilhelmine Meeraus
01 Sep 2017
Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation
A Ismaila ... C Compton
-
A Ismaila, et. al.A Ismaila ... C Compton
04 Sep 2022
Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
K Rothnie ... R Sharma
-
K Rothnie, et. al.K Rothnie ... R Sharma
04 Sep 2022
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
Correction.
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
--
01 Dec 2020
Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia.
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
--
01 Dec 2020
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group.
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
--
01 Nov 2020
Comprehensive Benefit-Risk Assessment of Noninferior Treatments Using Multicriteria Decision Analysis.
Yulia Sidi ... Ofer Harel
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 23
Yulia Sidi, et. al.Yulia Sidi ... Ofer Harel
29 Oct 2020
View more papers